Healthcare generative AI startup Hippocratic AI, which several health systems have invested in, is moving into life sciences with its acquisition of Grove AI.
Hippocratic AI has also named a president of life sciences, appointed a life sciences executive advisory council, and partnered with Boston Consulting Group on life sciences strategy.
The deal for Grove AI, which was unveiled Jan. 12, gives Hippocratic AI agentic AI capabilities for pharma research and development and clinical trial operations. Terms of the agreement were not disclosed.
Hippocratic AI, which reached “unicorn” status in 2025 with a $3.5 billion valuation, has had such health system investors as Cincinnati Children’s, Scottsdale, Ariz.-based HonorHealth, Columbus-based OhioHealth, King of Prussia, Pa.-based Universal Health Services and York, Pa.-based WellSpan Health.
The post Health system-backed Hippocratic AI acquires life sciences startup appeared first on Becker's Hospital Review | Healthcare News & Analysis.
Source: Read Original Article
